The Johns Hopkins University

Plamen A Demirev

Andrew B Feldman

Peter F Scholl

Miquel D Antoine

Nathan A Hagan

Rengaswamy Srinivasan

Jeffrey S Lin

Hassan M Saffarian

David J Sullivan

Brian Eduardo Damit

Felix C Sage

Kelly A Van Houten

Nirbhay Kumar

Benjamin B Alvarez

Charles A Fancher

Christopher J Rosenker

Jefffrey S Lin

Darin Kongkasuriyachai

Elizabeth C Corson

A cyclone includes a hollow cylindrical upper portion and a hollow conical lower portion having an inclined wall and a base wall. The base wall and the inclined wall are continuous contact with each other, and the inclined wall of the hollow conical lower portion is in continuous contact with an outer wall of the hollow cylindrical upper portion. A total cyclone height is from about 10 to about 30 millimeters, and a ratio of the total cyclone height to an inner diameter of the hollow cylindrical upper portion is from about 0.7 to about 1.3. An angle between an inner surface of the base wall and an inner surface of the inclined wall is from about 110 to about 130 degrees.

Cyclone and methods of manufacture thereof

The present invention is based on the discovery that drug resistance in microorganisms can be rapidly and accurately determined using mass spectrometry. A mass spectrum of an intact microorganism or one or more isolated biomarkers from the microorganism grown in drug containing, isotopically-labeled media is compared with a mass spectrum of the intact microorganism or one or more isolated biomarkers from the microorganism grown in non-labeled media without the drug present. Drug resistance is determined by predicting and detecting a characteristic mass shift of one or more biomarkers using algorithms. The characteristic mass shift is indicative that the microorganism is growing in the presence of the drug and incorporating the isotopic label into the one or more biomarkers, resulting in change in mass.

System for determining drug resistance in microorganisms

Systems and methods for determining drug resistance in microorganisms

Mass spectrometric techniques are provided for detecting the presence of parasites that accumulate unbound heme in red blood cells (including malaria parasites), based on the discovery that unbound heme can be detected and quantified using mass spectrometry. In one aspect of the invention, the method includes the steps of: obtaining a blood sample from the animal; preparing a test sample on a support from the blood sample, and inserting the support into a mass spectrometer for analysis. Next one obtains a mass spectrum of the test sample and determines whether the mass spectrum contains a mass/charge signature of unbound heme. If it is determined that the mass spectrum of the test sample shows the mass/charge signature of unbound heme, the animal is diagnosed as infected with malaria parasites.

Detection of malaria parasites by mass spectrometry

Methods are described for detecting and quantifying occult blood in a biological sample using laser desorption mass spectrometry (LD MS). Biological samples that can be analyzed using various embodiments of the present invention include stool (fecal occult blood, FOB), and any bodily fluid including urine, cerebrospinal fluid and other bodily fluids. If the heme or heme metabolite is bound to protein, the sample is treated with acid before analysis to release the porphyrin. Some of the methods use LD MS with a time of flight analyzer (TOF) to detect and measure unbound heme, other hemoglobin metabolites and other molecules that have a porphyrin-based structure, e.g., bilirubin, biliverdin, protoporphyrin IX, and Zinc protoporphyrin in the biological sample. In other methods, matrix-assisted laser desorption/ionization mass spectrometry (MALDI MS) is used to detect and quantify the individual &#x3b1;- and &#x3b2;-polypeptide chains of hemoglobin.

Occult blood detection in biological samples by laser desorption and matrix-assisted laser desorption/ionization mass spectrometry for biomedical applications

Provided are methods of producing an electrode capable of binding an analyte thereto comprising: providing a substrate capable of binding a dithiol molecule thereto; electrochemically treating the substrate using cyclic voltammetry to provide a treated substrate having a fractal dimension of greater than about 2; and contacting the treated substrate with dithiol molecules to produce an electrode having dithiol groups attached thereto and capable of binding an analyte to be detected thereto. Also provided are methods of accumulating and detecting analytes using the electrodes produced via the methods of the present invention.

Methods of producing electrodes and methods of using such electrodes to accumulate and detect analytes

Growing community of inventors

Ellicott City, MD, United States of America

Plamen A Demirev